drugset / Trial / NCT05561816
Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is aimed to: * evaluate the effectiveness of 10-day therapy with Dioxidin® compared with Miramistin® in the treatment of superficial pyoderma, * evaluate the safety and tolerability of 10-day therapy with Dioxidin® compared with Miramistin® for the treatment of superficial pyoderma.
Timeline
- Start
- 2022-07-19
- Primary completion
- 2022-11-28
- Completion
- 2022-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Benzyl-dimethyl-[3-(tetradecanoylamino)propyl]azanium | Small molecule | 0.01 % | Topical |
| Subject | DIOXYDINE | Small molecule | 0.025 % | Topical |